top of page
Doctor's Desk

At STOP T1D, we know that early detection leads to better outcomes.

Led by the Barbara Davis Center for Diabetes at the University of Colorado, our mission is twofold:

To raise awareness among Health Care Providers (HCP) and communities about the critical importance of early detection and the severe consequences of delayed diagnosis of Type 1 Diabetes

1

To educate and empower HCPs and healthcare organizations with the knowledge, competence, and tools necessary for effective screening, timely diagnosis, and age-specific monitoring practices. 

2

We ask ALL Health Care Providers to  SIGN UP 

See full course description and learning objectives below...

HCP Educational Modules

This innovative course is designed to provide health care providers with the knowledge and tools necessary to effectively promote and/or conduct screening for pre-symptomatic type 1 diabetes (T1D). Participants will gain a comprehensive understanding of the importance of early detection and monitoring of pre-symptomatic T1D, covering:

• Screening methods and confirmation

• Target populations

• Communication of results

• Patient monitoring

• Available intervention and clinical trial opportunities

• Implementation of screening and monitoring into health systems

By the end of the course, participants will be prepared to make a significant impact on the immediate and long-term health of people living with type 1 diabetes. 

The course seeks to bring innovation directly from research to clinical care. As such, this curriculum is a living document. Course participants will be eligible to receive ongoing updates as the field evolves. 

Earn CME Credits

​

You have the option to take this program with or without receiving 3.5 CME credits.

​

Details below...

LEARNING OBJECTIVES
Upon completing this course, health care providers will have improved ability to:
 

  1. Explain the significance of early detection of Type 1 Diabetes (T1D).

  2. Identify appropriate populations and screening methods for T1D.

  3. Apply monitoring protocols for individuals with positive autoantibodies.

  4. Demonstrate effective communication strategies when counseling patients with T1D and their families.

  5. Recognize the psychosocial impacts of T1D screening results.

  6. Discuss treatment options for T1D, including immunomodulatory therapies such as teplizumab..

  7. Collaborate effectively across interdisciplinary care teams to support T1D screening and management.

1.png
Pathophysiology and Natural History of Type 1 Diabetes
2.png
Introduction to T1D Screening
3.png
Epidemiology of T1D and Target Populations for Screening
4.png
Recognizing and Managing Early-Stage T1D in ED / Acute Care
5.png
Screening Methods
6.png
Confirmation of Positive Screening Results
7.png
Results Notification
8.png
Psychological Impact and Engagement
9.png
Monitoring and Managing Islet Autoantibody Positive Patients
10.png
FDA Approved Treatment for Pre-Symptomatic T1D
11.png
Clinical Trials
12.png
Implementing Screening and Monitoring into Healthcare Systems

MODULES

REGISTER
CME Credits Available

Health care professionals interested in earning  3.5 CME credits 
should click the link below to register with one of our CME-partners. 

(NOTE: Full Program can be completed over multiple visits.)

SIGN UP here to access the STOP T1D Program (without CME).

Returning HCPs (already signed up):

without CME

Enroll individuals with positive islet autoantibody screening in our Registry
LOGO-banner2.png

This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by a grant from Sanofi US.

Questions@STOPT1Dprogram.org

Call: 303-724-STOP

Version 4.0_06.2026  /  Design/Website: GSU

bottom of page